ArticleJournal of clinical and translational science2021

Rapid and sustained decline in CXCL-10 (IP-10) annotates clinical outcomes following TNFα-antagonist therapy in hospitalized patients with severe and critical COVID-19 respiratory failure.

Hilal Hachem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.